Technical Analysis for NTI - Neurotech International Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Reached Overbought | Strength | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
20 DMA Support | Bullish | 4.76% | |
MACD Bullish Signal Line Cross | Bullish | 4.76% | |
Gapped Down | Weakness | 4.76% | |
Crossed Above 20 DMA | Bullish | 7.32% | |
20 DMA Resistance | Bearish | 10.00% |
Alert | Time |
---|---|
Upper Bollinger Band Resistance | 1 day ago |
Rose Above Upper Bollinger Band | 1 day ago |
Up 2% | 1 day ago |
Up 3% | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Get a Trading Assistant
Neurotech International Ltd Description
Neurotech International Limited (Neurotech) is an Australia-based medical device and solutions company. The Company is focused on developing neuro-stimulation and neuro-diagnostic solutions. The Company delivers its solutions through the mente platform, a platform technology to enable medical practitioners to remotely monitor and play an active role in home-based therapies. Its product, Mente Autism, assists with the management of children with Autism Spectrum Disorder (ASD). Mente Autism is an electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to help relax the minds of children with ASD. It has a pipeline of products, which are split between the business-to-consumer (B2C) or end user/consumer family of products for home-use, such as Neurotech first product, Mente Autism, and the business-tobusiness (B2B) or business-focused family of products for clinical use. It operates through its subsidiary, AAT Research.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Medical Device Business To Business Neuroscience Platform Technology B2b Psychiatric Diagnosis Psychiatry Electroencephalography
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.125 |
52 Week Low | 0.031 |
Average Volume | 2,305,784 |
200-Day Moving Average | 0.065 |
50-Day Moving Average | 0.098 |
20-Day Moving Average | 0.100 |
10-Day Moving Average | 0.101 |
Average True Range | 0.007 |
RSI (14) | 58.16 |
ADX | 16.51 |
+DI | 26.912 |
-DI | 19.942 |
Chandelier Exit (Long, 3 ATRs) | 0.098 |
Chandelier Exit (Short, 3 ATRs) | 0.111 |
Upper Bollinger Bands | 0.110 |
Lower Bollinger Band | 0.090 |
Percent B (%b) | 1.02 |
BandWidth | 20.060 |
MACD Line | 0.002 |
MACD Signal Line | 0.001 |
MACD Histogram | 0.0007 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.122 | ||||
Resistance 3 (R3) | 0.121 | 0.115 | 0.120 | ||
Resistance 2 (R2) | 0.115 | 0.112 | 0.116 | 0.119 | |
Resistance 1 (R1) | 0.113 | 0.110 | 0.114 | 0.114 | 0.119 |
Pivot Point | 0.107 | 0.107 | 0.108 | 0.108 | 0.107 |
Support 1 (S1) | 0.105 | 0.104 | 0.106 | 0.106 | 0.101 |
Support 2 (S2) | 0.099 | 0.102 | 0.100 | 0.101 | |
Support 3 (S3) | 0.097 | 0.099 | 0.100 | ||
Support 4 (S4) | 0.098 |